Interview
with Neil Love, MD from Breast Cancer Update for Medical Oncologists,
Program 3 2000
Play
Audio Below:
I
actually, personally, use anastrozole. And, I’ll be real honest,
its because they were the first ones on the block I got used to
using it. When letrozole came out we actually looked in our pharmacy
because I said I’d use the cheaper one, whichever it was, and
there was no difference in cost between the two of them. It will
be interesting to see what happens with exemestane now that it’s
come on. I know there are reported to be responses in women who
have failed more traditional aromatase inhibitors. But it's wonderful
to have those drugs to choose from now and it has allowed me to
just discard some other things.
Critique
of survival update analysis from two phase III anastrozole clinical
trials. Buzdar, A. U.; Wood; Wolter; Vogel; Bland, and Ravdin.
Annals of Surgical Oncology. 6(8 Suppl S):8S-11S, 1999 Dec. No
abstract
ARIMIDEX'
as Neoadjuvant Therapy Causes Large Reductions in
Tumour
Volume in Postmenopausal Women with Large Operable Breast Cancers. (Meeting
abstract). Dixon Michael. Renshaw L. Bellamy C. Cameron DA.
Miller WR. Proc Annu Meet Am Soc Clin Oncol. 18:A345, 1999.
No Abstract.
Neoadjuvant
Treatment with Anastrozole ('ARIMIDEX') Causes Profound Suppression
of Intra-Tumor Estrogen Levels (Meeting abstract). Geisler Jurge. Bernsten H. Ottestad L. Lindtjorn B. Dowsett
M. Lonning PE. Proc Annu Meet Am Soc Clin Oncol 18:A311,
1999. No Abstract.
